Biologicals

Papers
(The TQCC of Biologicals is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?17
A practical approach for gmp-compliant validation of real-time PCR method for mycoplasma detection in human mesenchymal stromal cells as advanced therapy medicinal product14
Multiple antigenic peptide-based flow through dot-blot assay for simultaneous antibody detection of infectious bronchitis virus and Newcastle disease virus14
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA13
An overview of non-clinical safety studies in current Turkish regulations for the development of COVID-19 vaccines10
Aims and Scope/Editorial Board/Publishing Details9
Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients9
Stability of lyophilized Meningococcal A conjugate vaccine, (MenAfriVac™) at elevated temperatures to support controlled temperature chain (CTC) claim8
Report on the GHPP-BloodTrain online workshop on “Authorisation and Licensing of Blood Establishments - Review of quality documentation of blood and blood components”, 5th-8th of July 20218
Development and evaluation of recombinant gD protein based ELISA for sero-surveillance of BoHV-1 in India7
Development and characterization of mouse monoclonal antibodies to canine morbillivirus7
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus7
Preliminary study on serum immunoglobulin G responses following intramuscular inoculation of adjuvanted polyhydroxyalkanoate microparticles with Pasteurella multocida vaccine in white rats7
From discovery to innovation in animal health: Maturing emerging technologies for industrial development7
Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges7
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop7
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines6
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model6
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization6
Corrigendum to “Comparison of Astra Zeneca and sinopharm vaccines as boosters in protection against COVID-19 infection” [Biologicals 82 (2023) 101668]6
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 20236
A vision for patient-centric specifications for biologicals6
Aims and Scope/Editorial Board/Publishing Details5
Viral clearance capability of monoclonal antibody purification5
Circulation of yellow fever virus in Benin city, Edo state Nigeria5
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis5
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression5
An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG)4
Aims and Scope/Editorial Board/Publishing Details4
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency4
Glycoconjugate content quantification to assess vaccine potency: A simplified approach4
Development and validation of a spectrophotometric method for quantification of residual cyclodextrin (DIMEB; Heptakis) in pertussis antigens4
Development of an ELISA for the detection of fowl adenovirus serotype −4 utilizing fiber protein4
Accelerated national lot release on COVID-19 vaccines in Republic of Korea4
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques4
Aims and Scope/Editorial Board/Publishing Details4
Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report3
Adaptation and characterization of Anatid herpesvirus 1 in different permissible cell lines3
Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides3
Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines3
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools3
Emergence of SARS-CoV-2 variant of interest B.1.525 (Eta) in Bangladesh3
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?3
Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection3
It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study3
Computational identification of monkeypox virus epitopes to generate a novel vaccine antigen against Mpox3
A collaborative study to establish the second national standard for hepatitis B immunoglobulin in Korea3
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities3
Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats3
Development and evaluation of polymeric nanoparticles as a delivery system for snake envenoming prevention3
Adjuvant effect of mesoporous silica SBA-15 on anti-diphtheria and anti-tetanus humoral immune response3
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report3
Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales3
0.027580976486206